Key Record Dates
ClinicalTrials.gov Identifier: | NCT03787602 |
---|---|
Brief Title: | Navtemadlin (KRT-232) With or Without Anti-PD-1/Anti-PD-L1 for the Treatment of Patients With Merkel Cell Carcinoma |
First Submitted : | December 6, 2018 |
First Submitted that Met QC Criteria : | December 21, 2018 |
First Posted : | December 26, 2018 |
Last Update Submitted that Met QC Criteria : | February 28, 2023 |
Last Update Posted : | March 2, 2023 |